Document Type

Article

Version Deposited

Published Version

Publication Date

3-11-2024

Publication Title

Xenotransplantation

DOI

10.1111/xen.12847

Abstract

With decades of pre-clinical studies culminating in the recent clinical application of xenotransplantation, it would appear timely to provide recommendations for operationalizing oversight of xenotransplantation clinical trials. Ethical issues with clinical xenotransplantation have been described for decades, largely centering on animal welfare, the risks posed to the recipient, and public health risks posed by potential spread of xenozoonosis. Much less attention has been given to considerations relating to potentially elevated risks faced by those who may care for or otherwise have close contact with xenograft recipients. This paper examines the ethical and logistical issues raised by the potential exposure to xenozoonotic disease faced by close contacts of xenotransplant recipients-defined herein as including but not limited to caregivers, household contacts, and sexual partners-which warrants special attention given their increased risk of exposure to infection compared to the general public. We discuss implications of assent or consent by these close contacts to potentially undergo, along with the recipient, procedures for infection screening and possible quarantine. We then propose several options and recommendations for operationalizing oversight of xenotransplantation clinical trials that could account for and address close contacts' education on and agency regarding the risk of xenozoonosis.

Published Citation

Hurst DJ, Padilla L, Rodger D, Schiff T, Cooper DKC. Close contacts of xenograft recipients: ethical considerations due to risk of xenozoonosis. Xenotransplantation. 2024 Mar-Apr;31(2):e12847. doi: 10.1111/xen.12847. PMID: 38468191.

Share

COinS